Subscription Center
Jan 9, 2009 07:10 PM
Tamiflu, an antiviral used to treat the flu, doesn’t work against most of the virus circulating in the U.S. this season, federal officials say.
It's not a serious problem so far, because fewer than the usual number of people have caught the flu this year, U.S. Centers for Disease Control and Prevention (CDC) authorities say. But 99 percent of cases this year are resistant to the drug, compared to 11 percent last year, The New York Times reports.
The resistance seems to stem from a spontaneous mutation in the virus, not the result of overuse of the drug, according to the Times. They've advised patients to use a Tamiflu rival, Relenza, or an older med called rimantadine, according to Bloomberg News.
For more on why viruses become resistant to medications thanks to evolution—and the prospect of performing DNA analyses of an infection to decide how best to treat it—check out this article in this month's Scientific American.
Image of Tamiflu by Moriori via Wikimedia Commons
Tags:
flu,
influenza,
CDC,
tamiflu
More News Blog:
Next: Tonight's moon will rival last month's massive bright perigee
Previous: Will DTV transition be delayed?
See what we're tweeting about
DNLee5 Suddenly feeling warm. Why? My fan isn't working. Look up, the powerlight to water heater is off. Another blackout #dispatchesDNLee
sciencegoddess So many exciting space events! May 31, a giant asteroid will be flying by Earth. http://t.co/cyokKwOJhy DNLee5 you look awesome!! :) @SuzieZUMO @arikia @maggiekb1
Deadline: Jul 15 2013
Reward: $5,000 USD
SciBX: Science-Business eXchange, a joint publication from the makers
Deadline: Jul 30 2013
Reward: $100,000 USD
The Seeker desires a method for producing pseudoephedrine products in such a way that it will be extremely difficult for clandestine che
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
Comments
Add Comment